EPCAM and breast cancer: Because of their exquisite affinity and specificity, the anti-EpCAM aptamers discriminated breast cancer xenograft tissues, in tissue staining experiments with fluorescently labeled aptamers, depending on the expression level of EpCAM on cell surface [104].